A Prospective, Observational, Open-Label, Non-Randomized, Single Dose, Single centre, Two way, Parallel group, Bioequivalence Study of Two Formulations of Pemetrexed in Indian Adult Chemo-Naive, Adenocarcinoma NSCLC Patients.
Phase of Trial: Phase II
Latest Information Update: 03 Jul 2019
At a glance
- Drugs Pemetrexed (Primary)
- Indications Adenocarcinoma; Non-small cell lung cancer
- Focus Pharmacokinetics
- 03 Oct 2012 New trial record